Download FREE Report Sample
Download Free sampleSilymarin is a flavonolignans extracted from the milk thistle Silybum marianum (L.) gaernt. Silymarin has been shown to possess various pharmacological properties like hepatoprotective, antioxidant, antiinflammatory, anticancer, and cardioprotective activities.
Silymarin Market contains market size and forecasts of Silymarin in global, including the following market information:
Global Silymarin Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Silymarin Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Silymarin companies in 2021 (%)
The global Silymarin market was valued at 93 million in 2021 and is projected to reach US$ 114.4 million by 2028, at a CAGR of 3.1% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Silymarin Extracted by Acetone Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Silymarin include LIVERD PHARMA, Huacheng Pharmaceutical, TY Pharmaceutical, Teva API, KEB Biotech, Shengbo Silymarin, Panjin Fengrui and Jiaherb, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Silymarin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Silymarin Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Silymarin Market Segment Percentages, by Type, 2021 (%)
Silymarin Extracted by Acetone
Silymarin Extracted by Ethyl Acetate
Silymarin Extracted by Ethanol
Water Soluble Silymarin
Global Silymarin Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Silymarin Market Segment Percentages, by Application, 2021 (%)
Pharma and Healthcare
Food Additives
Cosmetic and Skin Care
Others
Global Silymarin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Silymarin Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Silymarin revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Silymarin revenues share in global market, 2021 (%)
Key companies Silymarin sales in global market, 2017-2022 (Estimated), (MT)
Key companies Silymarin sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
LIVERD PHARMA
Huacheng Pharmaceutical
TY Pharmaceutical
Teva API
KEB Biotech
Shengbo Silymarin
Panjin Fengrui
Jiaherb
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
